Market niche Target early-stage medical device buyers in ENT and outpatient office settings, focusing on low-pressure, gradual dilation technologies that enable in-office procedures under local anesthesia.

Product differentiation Position Vent-Os as a patient-tavorable alternative to balloon dilation with its osmotic, self-expanding design that minimizes discomfort and enables simple two-step procedures, appealing to clinics seeking efficient, in-office solutions.

Clinical strategy Leverage a unique dilation approach to pursue partnerships with small to mid-sized hospitals and ENT clinics looking to expand minimally invasive options for chronic sinusitis, potentially integrating with existing office-based workflows.

Financial path Focus sales conversations on cost of care and procedural efficiency given modest revenue figures and scaling potential as the product gains clinic adoption, highlighting potential for high-margin device sales and repeat usage.

Partnership leverage Target established medical device distributors and small-cap manufacturers with ENT portfolios to accelerate market entry, while underscoring compatibility with office-based settings and the company’s proprietary technology.